Artemis Medicare Services Ltd
Artemis Medicare Services Ltd (AMSL) was incorporated on 2004, by the promoters of the Apollo Tyres Group, is engaged in healthcare business. AMSL operates a 318-bedded multi-specialty tertiary care hospital in Gurgaon. It has specialization in various segments like Orthopedics & Joint Replacement, Oncology, Cardiovascular, Neurosciences and Bariatric & Minimally Invasive Surgery. AMSL has been awarded with the NABH accreditation.
Upcoming Capex:
Company has planned a brownfield expansion wherein, it will construct a new block of 144 beds at its existing location in Gurgaon.
Estimated cost of the project is 168 Cr, to be funded by a mix of debt-equity.
Project construction is underway and is expected to complete by Q1FY22.
This project was envisaged in 2017 and was expected to be operational by 2019. But, was suspended by the order of HSPCB and it got delayed by a few years. #
- Market Cap ₹ 265 Cr.
- Current Price ₹ 200
- High / Low ₹ 272 / 130
- Stock P/E
- Book Value ₹ 228
- Dividend Yield 0.00 %
- ROCE 10.4 %
- ROE 6.55 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.88 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|
547 | 565 | 418 | |
481 | 503 | 390 | |
Operating Profit | 66 | 62 | 28 |
OPM % | 12% | 11% | 7% |
Other Income | 2 | 4 | 4 |
Interest | 11 | 13 | 13 |
Depreciation | 20 | 23 | 22 |
Profit before tax | 37 | 31 | -3 |
Tax % | 45% | 36% | |
Net Profit | 20 | 20 | -2 |
EPS in Rs | 9.76 | 14.95 | -1.43 |
Dividend Payout % | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -26% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -109% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 16% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|
13 | 13 | 13 | |
Reserves | 280 | 300 | 289 |
Borrowings | 114 | 113 | 127 |
147 | 160 | 172 | |
Total Liabilities | 554 | 586 | 601 |
381 | 393 | 389 | |
CWIP | 49 | 56 | 57 |
Investments | 0 | 0 | 0 |
124 | 137 | 155 | |
Total Assets | 554 | 586 | 601 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | |
---|---|---|
40 | 56 | |
-50 | -26 | |
14 | -27 | |
Net Cash Flow | 5 | 2 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | |
---|---|---|
ROCE % | 10% | |
Debtor Days | 52 | 49 |
Inventory Turnover | 0.91 |
Documents
Recent announcements
- Compliance Certificate Under Regulation 7(3) For The Half Year Ended 31-03-2021 8 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr
- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 1 Apr
- Closure of Trading Window 31 Mar
- Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015) 16 Mar
View all